We know that you may be experiencing challenges trying to get your Wegovy™ prescription filled. We want to explain the situation and what we are doing to address it. We know you have questions and our goal is to provide the best possible support.

We made Wegovy™ available in the US in mid-June and since that time, the demand for this medicine has significantly exceeded our expectations and unfortunately, our initial product supply was not enough to meet all patient needs. We do have extensive production capacity and have already significantly increased the amount of medicine being manufactured. And although it will take us some time, we are confident in our ability to improve supply and better meet demand in the coming months.

What does this mean for you?

The implications are that you may not be able to start treatment with Wegovy™ as quickly as you may like, which we regret. Currently, you may experience a month-long delay or longer in getting your Wegovy™ prescriptions filled, potentially lasting throughout the remainder of the year. We believe we will stabilize supply in early 2022, if not sooner, depending on demand.

We are also working to ensure that those of you who have already started can continue therapy, which means doing what we can in the short-term to manage the number of people initiating treatment with Wegovy™.

Please see a message from Doug Langa, executive vice president, North America operations and president of Novo Nordisk Inc:

“Many of you took an important step to talk to a healthcare provider about managing your weight, and we fully understand your disappointment with these delays in getting started on Wegovy™.  We are sorry that we are not meeting your needs as we would have liked. Please know that we take our responsibility to support you in this journey very seriously and are addressing this issue as a top priority. We are taking every necessary step to meet current and future needs. Thank you for your patience as we work to resolve this issue – which we will, as we know this medicine has the potential to make a meaningful difference for many people for years to come.”

Wegovy™ is a prescription medicine indicated for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems to help them lose weight and keep it off used with a reduced-calorie meal plan and increased physical activity.

Please see below for important information, and don’t hesitate to call 1-833-4-WEGOVY (1-833-493-4689) and select option 0 for more support. You are our number one priority and we’re here to help.

Please click here for Important Safety Information, Full Prescribing Information and Medication Guide.

We have ramped up production and assembly at our facilities to increase supply. While current supply challenges may continue throughout the rest of this year, we believe we will stabilize supply in early 2022, if not sooner, depending on demand. Please check back here regularly for updates on Wegovy™ supply and additional guidance. 

There are five different doses of Wegovy™: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg. 

While current supply challenges may continue throughout the rest of this year, we believe we will stabilize supply in early 2022, if not sooner, depending on demand. We will share regular updates as doses become available.

For more information about the Wegovy™ dosing schedule, please visit: www.wegovy.com/about-wegovy/dosing-schedule.html.

If your healthcare provider has written you a prescription for Wegovy™ and you are eligible for copay savings, our Standard Copay Savings offer allows patients to pay as little as $25 per 28-day supply of Wegovy™, subject to a maximum savings of $200 per 28-day supply. Eligible patients can download the savings offer and view terms and conditions online at https://www.novocare.com/wegovy/savings-card.html.

Due to the high demand for Wegovy™, we are no longer distributing additional Wegovy™ Limited-Time Savings offers to healthcare providers, effective August 16, 2021. This was not a decision that we took lightly. We did not feel we would be acting responsibly by continuing to offer programs that could contribute to increased demand at a time when we are not able to meet it. 

Eligible patients who receive the Limited-Time Savings offer from their healthcare provider after August 16, 2021 can still use this offer. To receive this 6-month savings offer, activate the card and sign up for WeGoTogether™ support at SaveOnWegovy.com by December 31, 2021. WeGoTogether™  provides free access to a live or digital coach dedicated to helping you manage your weight, online resources and ongoing support to keep you motivated.

Additionally, if you are currently enrolled in any of our savings programs, please know that we will continue to honor these, as well.  

We encourage you to speak with your health care provider about what decision may be right for you. 

We encourage you to speak with your health care provider about what decision may be right for you. We caution those ready to start treatment to wait for the 0.25 mg starting dose of Wegovy™, rather than skipping to a higher dose, as that could cause unwanted side effects. Importantly, the final decision as to how you take this medication should be made by your health care provider.

For more information about the Wegovy™ dosing schedule, please visit here: www.wegovy.com/about-wegovy/dosing-schedule.html.

While current supply challenges may continue throughout the rest of this year, we believe we will stabilize supply in early 2022, if not sooner, depending on demand.

Please check back here regularly for updates on Wegovy™ supply and additional guidance.


What is Wegovy™?

Wegovy™ (semaglutide) injection 2.4 mg is an injectable prescription medicine used for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems to help them lose weight and keep the weight off.

  • Wegovy should be used with a reduced calorie meal plan and increased physical activity.
  • Wegovy contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
  • It is not known if Wegovy™ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products.
  • It is not known if Wegovy™ can be used safely in people with a history of pancreatitis.
  • It is not known if Wegovy™ is safe and effective for use in children under 18 years of age.


What is the most important information I should know about Wegovy™?

Wegovy™ may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy™ and medicines that work like Wegovy™ caused thyroid tumors, including thyroid cancer. It is not known if Wegovy™ will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
  • Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Do not use Wegovy™ if:

  • you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy.

Before using Wegovy™, tell your healthcare provider if you have any other medical conditions, including if you:

  • have or have had problems with your pancreas or kidneys.
  • have type 2 diabetes and a history of diabetic retinopathy.
  • have or have had depression, suicidal thoughts, or mental health issues.
  • are pregnant or plan to become pregnant. Wegovy™ may harm your unborn baby. You should stop using Wegovy 2 months before you plan to become pregnant.
  • are breastfeeding or plan to breastfeed. It is not known if Wegovy™ passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy™ may affect the way some medicines work and some medicines may affect the way Wegovy™ works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy slows stomach emptying and can affect medicines that need to pass through the stomach quickly.

What are the possible side effects of Wegovy™?

Wegovy™ may cause serious side effects, including:

  • inflammation of your pancreas (pancreatitis). Stop using Wegovy™ and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • gallbladder problems. Wegovy may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
  • increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin. This can be both a serious and common side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery.
  • kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
  • serious allergic reactions. Stop using Wegovy™ and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat. 
  • change in vision in patients with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy.
  • increased heart rate. Wegovy™ can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes.
  • depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse or worry you.
  • the most common side effects of Wegovy™ may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu and heartburn.

Was this helpful?

Was this helpful?

Let us know! Please rate your experience with this page. *

{{crossValidationError['Was this page helpful'].crossValidationErrorMessage}}

If you have additional comments or would like to provide feedback on what other information would be helpful to you, please contact our Customer Care Center at 1-800-727-6500 or submit online. We will be reviewing that information on an ongoing basis and making periodic updates to this page. Please know that we take our responsibility to support you in this journey very seriously and are addressing this issue as a top priority. Thank you for your patience as we work to resolve this issue – which we will.

Your Career Guide